1
|
Dickinson MC, Wirth SE, Baker D, Kidney AM, Mitchell KK, Nazarian EJ, Shudt M, Thompson LM, Gubbala Venkata SL, Musser KA, Mingle L. Implementation of a high-throughput whole genome sequencing approach with the goal of maximizing efficiency and cost effectiveness to improve public health. Microbiol Spectr 2024; 12:e0388523. [PMID: 38451098 DOI: 10.1128/spectrum.03885-23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2023] [Accepted: 02/20/2024] [Indexed: 03/08/2024] Open
Abstract
This manuscript describes the development of a streamlined, cost-effective laboratory workflow to meet the demands of increased whole genome sequence (WGS) capacity while achieving mandated quality metrics. From 2020 to 2021, the Wadsworth Center Bacteriology Laboratory (WCBL) used a streamlined workflow to sequence 5,743 genomes that contributed sequence data to nine different projects. The combined use of the QIAcube HT, Illumina DNA Prep using quarter volume reactions, and the NextSeq allowed the WCBL to process all samples that required WGS while also achieving a median turn-around time of 7 days (range 4 to 10 days) and meeting minimum sequence quality requirements. Public Health Laboratories should consider implementing these methods to aid in meeting testing requirements within budgetary restrictions. IMPORTANCE Public Health Laboratories that implement whole genome sequencing (WGS) technologies may struggle to find the balance between sample volume and cost effectiveness. We present a method that allows for sequencing of a variety of bacterial isolates in a cost-effective manner. This report provides specific strategies to implement high-volume WGS, including an innovative, low-cost solution utilizing a novel quarter volume sequencing library preparation. The methods described support the use of high-throughput DNA extraction and WGS within budgetary constraints, strengthening public health responses to outbreaks and disease surveillance.
Collapse
Affiliation(s)
- Michelle C Dickinson
- Wadsworth Center, New York State Department of Health (NYSDOH), Division of Infectious Diseases Bacteriology Laboratory, Albany, New York, USA
| | - Samantha E Wirth
- Wadsworth Center, New York State Department of Health (NYSDOH), Division of Infectious Diseases Bacteriology Laboratory, Albany, New York, USA
| | - Deborah Baker
- Wadsworth Center, New York State Department of Health (NYSDOH), Division of Infectious Diseases Bacteriology Laboratory, Albany, New York, USA
| | - Anna M Kidney
- Wadsworth Center, New York State Department of Health (NYSDOH), Division of Infectious Diseases Bacteriology Laboratory, Albany, New York, USA
| | - Kara K Mitchell
- Wadsworth Center, New York State Department of Health (NYSDOH), Division of Infectious Diseases Bacteriology Laboratory, Albany, New York, USA
| | - Elizabeth J Nazarian
- Wadsworth Center, New York State Department of Health (NYSDOH), Division of Infectious Diseases Bacteriology Laboratory, Albany, New York, USA
| | - Matthew Shudt
- Wadsworth Center, New York State Department of Health (NYSDOH), Advanced Genomic Technologies Cluster, Albany, New York, USA
| | - Lisa M Thompson
- Wadsworth Center, New York State Department of Health (NYSDOH), Division of Infectious Diseases Bacteriology Laboratory, Albany, New York, USA
| | - Sai Laxmi Gubbala Venkata
- Wadsworth Center, New York State Department of Health (NYSDOH), Division of Infectious Diseases Bacteriology Laboratory, Albany, New York, USA
| | - Kimberlee A Musser
- Wadsworth Center, New York State Department of Health (NYSDOH), Division of Infectious Diseases Bacteriology Laboratory, Albany, New York, USA
| | - Lisa Mingle
- Wadsworth Center, New York State Department of Health (NYSDOH), Division of Infectious Diseases Bacteriology Laboratory, Albany, New York, USA
| |
Collapse
|
2
|
Ghani N, Baker H, Huntsinger A, Chen T, Familara TD, Itorralba JY, Vanderford F, Zhuang X, Chang CL, Vo V, Oh EC. Science Education for the Youth (SEFTY): A Neuroscience Outreach Program for High School Students in Southern Nevada during the COVID-19 Pandemic. eNeuro 2024; 11:ENEURO.0039-24.2024. [PMID: 38527805 PMCID: PMC10999729 DOI: 10.1523/eneuro.0039-24.2024] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2024] [Revised: 02/20/2024] [Accepted: 02/20/2024] [Indexed: 03/27/2024] Open
Abstract
Laboratory outreach programs for K-12 students in the United States from 2020 to 2022 were suspended or delayed due to COVID-19 restrictions. While Southern Nevada also observed similar closures for onsite programs, we and others hypothesized that in-person laboratory activities could be prioritized after increasing vaccine doses were available to the public and masking was encouraged. Here, we describe how the Laboratory of Neurogenetics and Precision Medicine at the University of Nevada Las Vegas (UNLV) collaborated with administrators from a local school district to conduct training activities for high school students during the COVID-19 pandemic. The Science Education for the Youth (SEFTY) program's curriculum was constructed to incorporate experiential learning, fostering collaboration and peer-to-peer knowledge exchange. Leveraging neuroscience tools from our UNLV laboratory, we engaged with 117 high school applicants from 2021 to 2022. Our recruitment efforts yielded a diverse cohort, with >41% Pacific Islander and Asian students, >9% African American students, and >12% multiracial students. We assessed the impact of the SEFTY program through pre- and postassessment student evaluations, revealing a significant improvement of 20.3% in science proficiency (p < 0.001) after participating in the program. Collectively, our laboratory curriculum offers valuable insights into the capacity of an outreach program to actively foster diversity and cultivate opportunities for academic excellence, even in the challenging context of a global pandemic.
Collapse
Affiliation(s)
- Nabih Ghani
- Laboratory of Neurogenetics and Precision Medicine, College of Sciences, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, Nevada 89154
- Doctor of Medicine Program, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, Nevada 89154
| | - Hayley Baker
- Laboratory of Neurogenetics and Precision Medicine, College of Sciences, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, Nevada 89154
- Doctor of Medicine Program, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, Nevada 89154
| | - Audrey Huntsinger
- Laboratory of Neurogenetics and Precision Medicine, College of Sciences, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, Nevada 89154
| | - Tiffany Chen
- Laboratory of Neurogenetics and Precision Medicine, College of Sciences, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, Nevada 89154
- Doctor of Medicine Program, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, Nevada 89154
| | - Tiffany D Familara
- Laboratory of Neurogenetics and Precision Medicine, College of Sciences, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, Nevada 89154
| | - Jose Yani Itorralba
- Laboratory of Neurogenetics and Precision Medicine, College of Sciences, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, Nevada 89154
| | - Fritz Vanderford
- Laboratory of Neurogenetics and Precision Medicine, College of Sciences, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, Nevada 89154
| | - Xiaowei Zhuang
- Laboratory of Neurogenetics and Precision Medicine, College of Sciences, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, Nevada 89154
- Neuroscience Interdisciplinary Ph.D. program, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, Nevada 89154
| | - Ching-Lan Chang
- Laboratory of Neurogenetics and Precision Medicine, College of Sciences, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, Nevada 89154
- Neuroscience Interdisciplinary Ph.D. program, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, Nevada 89154
| | - Van Vo
- Laboratory of Neurogenetics and Precision Medicine, College of Sciences, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, Nevada 89154
| | - Edwin C Oh
- Laboratory of Neurogenetics and Precision Medicine, College of Sciences, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, Nevada 89154
- Neuroscience Interdisciplinary Ph.D. program, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, Nevada 89154
- Department of Brain Health, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, Nevada 89154
- Department of Internal Medicine, Kirk Kerkorian School of Medicine at University of Nevada Las Vegas, Las Vegas, Nevada 89154
| |
Collapse
|
3
|
Rowe T, Davis W, Wentworth DE, Ross T. Differential interferon responses to influenza A and B viruses in primary ferret respiratory epithelial cells. J Virol 2024; 98:e0149423. [PMID: 38294251 PMCID: PMC10878268 DOI: 10.1128/jvi.01494-23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2023] [Accepted: 12/02/2023] [Indexed: 02/01/2024] Open
Abstract
Influenza B viruses (IBV) cocirculate with influenza A viruses (IAV) and cause periodic epidemics of disease, yet antibody and cellular responses following IBV infection are less well understood. Using the ferret model for antisera generation for influenza surveillance purposes, IAV resulted in robust antibody responses following infection, whereas IBV required an additional booster dose, over 85% of the time, to generate equivalent antibody titers. In this study, we utilized primary differentiated ferret nasal epithelial cells (FNECs) which were inoculated with IAV and IBV to study differences in innate immune responses which may result in differences in adaptive immune responses in the host. FNECs were inoculated with IAV (H1N1pdm09 and H3N2 subtypes) or IBV (B/Victoria and B/Yamagata lineages) and assessed for 72 h. Cells were analyzed for gene expression by quantitative real-time PCR, and apical and basolateral supernatants were assessed for virus kinetics and interferon (IFN), respectively. Similar virus kinetics were observed with IAV and IBV in FNECs. A comparison of gene expression and protein secretion profiles demonstrated that IBV-inoculated FNEC expressed delayed type-I/II IFN responses and reduced type-III IFN secretion compared to IAV-inoculated cells. Concurrently, gene expression of Thymic Stromal Lymphopoietin (TSLP), a type-III IFN-induced gene that enhances adaptive immune responses, was significantly downregulated in IBV-inoculated FNECs. Significant differences in other proinflammatory and adaptive genes were suppressed and delayed following IBV inoculation. Following IBV infection, ex vivo cell cultures derived from the ferret upper respiratory tract exhibited reduced and delayed innate responses which may contribute to reduced antibody responses in vivo.IMPORTANCEInfluenza B viruses (IBV) represent nearly one-quarter of all human influenza cases and are responsible for significant clinical and socioeconomic impacts but do not pose the same pandemic risks as influenza A viruses (IAV) and have thus received much less attention. IBV accounts for greater severity and deaths in children, and vaccine efficacy remains low. The ferret can be readily infected with human clinical isolates and demonstrates a similar course of disease and immune responses. IBV, however, generates lower antibodies in ferrets than IAV following the challenge. To determine whether differences in initial innate responses following infection may affect the development of robust adaptive immune responses, ferret respiratory tract cells were isolated, infected with IAV/IBV, and compared. Understanding the differences in the initial innate immune responses to IAV and IBV may be important in the development of more effective vaccines and interventions to generate more robust protective immune responses.
Collapse
Affiliation(s)
- Thomas Rowe
- Centers for Disease Control and Prevention, Influenza Division, Atlanta, Georgia, USA
- Center for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA
| | - William Davis
- Centers for Disease Control and Prevention, Influenza Division, Atlanta, Georgia, USA
| | - David E. Wentworth
- Centers for Disease Control and Prevention, Influenza Division, Atlanta, Georgia, USA
| | - Ted Ross
- Center for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA
| |
Collapse
|
4
|
Espinoza B, Adiga A, Venkatramanan S, Warren AS, Chen J, Lewis BL, Vullikanti A, Swarup S, Moon S, Barrett CL, Athreya S, Sundaresan R, Chandru V, Laxminarayan R, Schaffer B, Poor HV, Levin SA, Marathe MV. Coupled models of genomic surveillance and evolving pandemics with applications for timely public health interventions. Proc Natl Acad Sci U S A 2023; 120:e2305227120. [PMID: 37983514 PMCID: PMC10691339 DOI: 10.1073/pnas.2305227120] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2023] [Accepted: 10/13/2023] [Indexed: 11/22/2023] Open
Abstract
Disease surveillance systems provide early warnings of disease outbreaks before they become public health emergencies. However, pandemics containment would be challenging due to the complex immunity landscape created by multiple variants. Genomic surveillance is critical for detecting novel variants with diverse characteristics and importation/emergence times. Yet, a systematic study incorporating genomic monitoring, situation assessment, and intervention strategies is lacking in the literature. We formulate an integrated computational modeling framework to study a realistic course of action based on sequencing, analysis, and response. We study the effects of the second variant's importation time, its infectiousness advantage and, its cross-infection on the novel variant's detection time, and the resulting intervention scenarios to contain epidemics driven by two-variants dynamics. Our results illustrate the limitation in the intervention's effectiveness due to the variants' competing dynamics and provide the following insights: i) There is a set of importation times that yields the worst detection time for the second variant, which depends on the first variant's basic reproductive number; ii) When the second variant is imported relatively early with respect to the first variant, the cross-infection level does not impact the detection time of the second variant. We found that depending on the target metric, the best outcomes are attained under different interventions' regimes. Our results emphasize the importance of sustained enforcement of Non-Pharmaceutical Interventions on preventing epidemic resurgence due to importation/emergence of novel variants. We also discuss how our methods can be used to study when a novel variant emerges within a population.
Collapse
Affiliation(s)
- Baltazar Espinoza
- Network Systems Science and Advanced Computing Division, Biocomplexity Institute, University of Virginia, Charlottesville, VA22904
| | - Aniruddha Adiga
- Network Systems Science and Advanced Computing Division, Biocomplexity Institute, University of Virginia, Charlottesville, VA22904
| | - Srinivasan Venkatramanan
- Network Systems Science and Advanced Computing Division, Biocomplexity Institute, University of Virginia, Charlottesville, VA22904
| | - Andrew Scott Warren
- Network Systems Science and Advanced Computing Division, Biocomplexity Institute, University of Virginia, Charlottesville, VA22904
| | - Jiangzhuo Chen
- Network Systems Science and Advanced Computing Division, Biocomplexity Institute, University of Virginia, Charlottesville, VA22904
| | - Bryan Leroy Lewis
- Network Systems Science and Advanced Computing Division, Biocomplexity Institute, University of Virginia, Charlottesville, VA22904
| | - Anil Vullikanti
- Network Systems Science and Advanced Computing Division, Biocomplexity Institute, University of Virginia, Charlottesville, VA22904
- Department of Computer Science, University of Virginia, Charlottesville, VA22904
| | - Samarth Swarup
- Network Systems Science and Advanced Computing Division, Biocomplexity Institute, University of Virginia, Charlottesville, VA22904
| | - Sifat Moon
- Network Systems Science and Advanced Computing Division, Biocomplexity Institute, University of Virginia, Charlottesville, VA22904
| | - Christopher Louis Barrett
- Network Systems Science and Advanced Computing Division, Biocomplexity Institute, University of Virginia, Charlottesville, VA22904
- Department of Computer Science, University of Virginia, Charlottesville, VA22904
| | - Siva Athreya
- Indian Statistical Institute, Bengaluru, Karnataka560059, India
- International Centre for Theoretical Sciences, Bengaluru, Karnataka560089, India
| | - Rajesh Sundaresan
- Department of Electrical and Communication Engineering, Indian Institute of Science, Bengaluru, Karnataka560012, India
- Robert Bosch Centre for Cyber-Physical Systems, Indian Institute of Science, Bengaluru, Karnataka560012, India
- Centre for Networked Intelligence, Indian Institute of Science, Bengaluru, Karnataka560012, India
| | - Vijay Chandru
- Strand Life Sciences, Bengaluru, Karnataka560024, India
- BioSystems Science and Engineering, Indian Institute of Science, Bengaluru, Karnataka560012, India
| | | | - Benjamin Schaffer
- Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ08544
- Department of Electrical and Computer Engineering, Princeton University, Princeton, NJ08544
| | - H. Vincent Poor
- Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ08544
| | - Simon A. Levin
- Department of Ecology and Evolutionary Biology, Princeton University, Princeton, NJ08544
| | - Madhav V. Marathe
- Network Systems Science and Advanced Computing Division, Biocomplexity Institute, University of Virginia, Charlottesville, VA22904
- Department of Computer Science, University of Virginia, Charlottesville, VA22904
| |
Collapse
|
5
|
Kinney AY, Stroup AM, Scharf S, Libutti SK. Rutgers Cancer Institute of New Jersey's Community Outreach and Engagement Approach to Cancer Prevention. Cancer Prev Res (Phila) 2023; 16:595-600. [PMID: 37908146 PMCID: PMC10618643 DOI: 10.1158/1940-6207.capr-23-0293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2023] [Revised: 08/16/2023] [Accepted: 08/16/2023] [Indexed: 11/02/2023]
Abstract
Rutgers Cancer Institute of New Jersey (New Brunswick, NJ) is committed to providing cancer prevention education, outreach, and clinical services in our catchment area (CA). Our approach to cancer prevention includes ongoing surveillance to better understand the CA cancer burden and opportunities for intervention, leveraging community partnerships, and vigorously engaging diverse communities to understand and address their needs. This approach considers individual, sociocultural, environmental, biologic, system, and policy-level factors with an equity lens. Rutgers Cancer Institute has had substantial impact on cancer prevention (risk reduction, screening, and early detection) over the past five years, including the development of a CA data dashboard advancing implementation of evidence-based cancer control actions by leveraging 357 healthcare and community partners (with 522 partner sites). Furthermore, we provided professional education (attendance 19,397), technical assistance to community organizations (1,875 support sessions), educational outreach for community members (87,000+ through direct education), facilitated access to preventive services (e.g., 60,000+ screenings resulting in the detection of >2,000 malignant and premalignant lesions), contributed to advances in health policy and population-level improvements in risk reduction behaviors, screening, and incidence. With longer-term data, we will assess the impact of our cancer prevention efforts on cancer incidence, downward shifts in stage at diagnosis, mortality, and disparities.
Collapse
Affiliation(s)
- Anita Y. Kinney
- Rutgers University School of Public Health, Rutgers, The State University of New Jersey, Piscataway, New Jersey
- Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
| | - Antoinette M. Stroup
- Rutgers University School of Public Health, Rutgers, The State University of New Jersey, Piscataway, New Jersey
- Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
| | - Sarah Scharf
- Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
| | - Steven K. Libutti
- Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey
- Robert Wood Johnson Medical School, New Brunswick, New Jersey
| |
Collapse
|
6
|
Arts PJ, Kelly JD, Midgley CM, Anglin K, Lu S, Abedi GR, Andino R, Bakker KM, Banman B, Boehm AB, Briggs-Hagen M, Brouwer AF, Davidson MC, Eisenberg MC, Garcia-Knight M, Knight S, Peluso MJ, Pineda-Ramirez J, Diaz Sanchez R, Saydah S, Tassetto M, Martin JN, Wigginton KR. Longitudinal and quantitative fecal shedding dynamics of SARS-CoV-2, pepper mild mottle virus, and crAssphage. mSphere 2023; 8:e0013223. [PMID: 37338211 PMCID: PMC10506459 DOI: 10.1128/msphere.00132-23] [Citation(s) in RCA: 10] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/13/2023] [Accepted: 05/03/2023] [Indexed: 06/21/2023] Open
Abstract
Wastewater-based epidemiology (WBE) emerged during the coronavirus disease 2019 (COVID-19) pandemic as a scalable and broadly applicable method for community-level monitoring of infectious disease burden. The lack of high-resolution fecal shedding data for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) limits our ability to link WBE measurements to disease burden. In this study, we present longitudinal, quantitative fecal shedding data for SARS-CoV-2 RNA, as well as for the commonly used fecal indicators pepper mild mottle virus (PMMoV) RNA and crAss-like phage (crAssphage) DNA. The shedding trajectories from 48 SARS-CoV-2-infected individuals suggest a highly individualized, dynamic course of SARS-CoV-2 RNA fecal shedding. Of the individuals that provided at least three stool samples spanning more than 14 days, 77% had one or more samples that tested positive for SARS-CoV-2 RNA. We detected PMMoV RNA in at least one sample from all individuals and in 96% (352/367) of samples overall. CrAssphage DNA was detected in at least one sample from 80% (38/48) of individuals and was detected in 48% (179/371) of all samples. The geometric mean concentrations of PMMoV and crAssphage in stool across all individuals were 8.7 × 104 and 1.4 × 104 gene copies/milligram-dry weight, respectively, and crAssphage shedding was more consistent for individuals than PMMoV shedding. These results provide us with a missing link needed to connect laboratory WBE results with mechanistic models, and this will aid in more accurate estimates of COVID-19 burden in sewersheds. Additionally, the PMMoV and crAssphage data are critical for evaluating their utility as fecal strength normalizing measures and for source-tracking applications. IMPORTANCE This research represents a critical step in the advancement of wastewater monitoring for public health. To date, mechanistic materials balance modeling of wastewater-based epidemiology has relied on SARS-CoV-2 fecal shedding estimates from small-scale clinical reports or meta-analyses of research using a wide range of analytical methodologies. Additionally, previous SARS-CoV-2 fecal shedding data have not contained sufficient methodological information for building accurate materials balance models. Like SARS-CoV-2, fecal shedding of PMMoV and crAssphage has been understudied to date. The data presented here provide externally valid and longitudinal fecal shedding data for SARS-CoV-2, PMMoV, and crAssphage which can be directly applied to WBE models and ultimately increase the utility of WBE.
Collapse
Affiliation(s)
- Peter J. Arts
- Department of Civil and Environmental Engineering, University of Michigan, Ann Arbor, Michigan, USA
| | - J. Daniel Kelly
- Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA
- Institute for Global Health Sciences, University of California, San Francisco, California, USA
- Division of Hospital Medicine, UCSF, San Francisco, California, USA
- F.I. Proctor Foundation, University of California, San Francisco, California, USA
| | - Claire M. Midgley
- National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Khamal Anglin
- Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA
- Institute for Global Health Sciences, University of California, San Francisco, California, USA
| | - Scott Lu
- Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA
- Institute for Global Health Sciences, University of California, San Francisco, California, USA
| | - Glen R. Abedi
- National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Raul Andino
- Department of Microbiology and Immunology, UCSF, San Francisco, California, USA
| | - Kevin M. Bakker
- Department of Epidemiology, University of Michigan, Ann Arbor, Michigan, USA
| | - Bryon Banman
- Department of Civil and Environmental Engineering, University of Michigan, Ann Arbor, Michigan, USA
| | - Alexandria B. Boehm
- Department of Civil & Environmental Engineering, Stanford University, Stanford, California, USA
| | - Melissa Briggs-Hagen
- National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Andrew F. Brouwer
- Department of Epidemiology, University of Michigan, Ann Arbor, Michigan, USA
| | | | - Marisa C. Eisenberg
- Department of Epidemiology, University of Michigan, Ann Arbor, Michigan, USA
| | | | - Sterling Knight
- Department of Civil and Environmental Engineering, University of Michigan, Ann Arbor, Michigan, USA
| | - Michael J. Peluso
- Division of HIV, Infectious Disease, and Global Medicine, UCSF, San Francisco, California, USA
| | - Jesus Pineda-Ramirez
- Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA
- Institute for Global Health Sciences, University of California, San Francisco, California, USA
| | - Ruth Diaz Sanchez
- Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA
- Institute for Global Health Sciences, University of California, San Francisco, California, USA
| | - Sharon Saydah
- National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Michel Tassetto
- Department of Microbiology and Immunology, UCSF, San Francisco, California, USA
| | - Jeffrey N. Martin
- Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA
| | - Krista R. Wigginton
- Department of Civil and Environmental Engineering, University of Michigan, Ann Arbor, Michigan, USA
| |
Collapse
|